D-0331-2026 Class II Ongoing
FDA drug recall D-0331-2026 was initiated by F.H. INVESTMENTS, Inc. (dba Asteria Health) on January 26, 2026 and is designated Class II. Reason for recall: Presence of Foreign substance - potential presence of metal particulate matter The recall status is ongoing. Affected quantity: 1,464 pellets..
Recall Details
- Product Type
- Drugs
- Report Date
- February 18, 2026
- Initiation Date
- January 26, 2026
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,464 pellets.
Product Description
Testosterone 100mg Anastrozole 4mg , 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-4104-32
Reason for Recall
Presence of Foreign substance - potential presence of metal particulate matter
Distribution Pattern
Nationwide in the USA
Code Information
Lot#: 254000105, Exp. 05/28/2026, 254000110, Exp. 08/07/2026; 254000112, 254000113, Exp. 09/26/2026.